Additional information
White Powder
1159977-36-2
ACI-025802
168.8-170.1°C
C18H14F4N2O4S
430.37
Ambient
2-8°C
Anticancer
Pharmaceutical Impurity Standards
(2RS)-N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(2-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide
N-[4-Cyano-3-trifluoromethyl)phenyl]-3-[(2-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide
2-Fluoro-4-Desfluoro Bicalutamide





![N-METHYL REGADENOSON (25 mg) (1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]-N,N-dimethylpyrazole-4-carboxamide )](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)